Rochelle Park-based TKL Research announced Friday it has opened a new primary research clinic in Fair Lawn.
According to the announcement, the 20,000-square-foot facility increased the company’s space by 70 percent over its prior clinic. It has a 30-bed Phase 1 pharmacology unit and multiple examination rooms for outpatient studies. The clinic is located in the newly constructed Fair Lawn Promenade.
“The Fair Lawn research facility will enable us to meet the increased demand for our services in the diseased-state populations for Phase I clinical trials in which we have strong patient recruitment expertise,” said Jon C. Anderson, Ph.D., TKL research president and CEO.
ALSO ON NJBIZ: